23rd June 2022
We are excited to announce the seven start-ups from the DACH region that moves towards the Catapult semifinals!
Meet the start-ups selected from the DACH region to continue their EIT Health Catapult journey! They have been selected from 42 start-ups from across Europe and will advance to the next phase of the programme.
The DACH regional selection ended with the selection of:
⭐ Ablevia biotech GmbH [Austria, BioTech]
⭐ PRAMOMOLECULAR GmbH [Germany, BioTech]
⭐ Freiburger Medizintechnik GmbH [Germany, MedTech]
⭐ Biome Diagnostics [Austria, MedTech]
⭐ XUND [Austria, Digital Health]
⭐ deepeye [Germany, Digital Health]
⭐ edupression.com [Austria, Digital Health]
The 7 projects combine technology and product development in a way that is truly innovative and has the potential to create a better future for European citizens.